91 related articles for article (PubMed ID: 3014694)
1. Epstein-Barr virus infection and immunity in bone marrow transplant recipients.
Crawford DH; Mulholland N; Iliescu V; Hawkins R; Powles R
Transplantation; 1986 Jul; 42(1):50-4. PubMed ID: 3014694
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr (EB) virus infection in homosexual men in London.
Crawford DH; Weller I; Iliescu V; Wara DW
Br J Vener Dis; 1984 Aug; 60(4):258-64. PubMed ID: 6331569
[TBL] [Abstract][Full Text] [Related]
3. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.
Gratama JW; Oosterveer MA; Lepoutre JM; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Richel D; Klein G; Ernberg I
Transplantation; 1990 Apr; 49(4):725-30. PubMed ID: 2158159
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-related serology in marrow transplant recipients.
Lange B; Henle W; Meyers JD; Yang LC; August C; Koch P; Arbeter A; Henle G
Int J Cancer; 1980 Aug; 26(2):151-7. PubMed ID: 6259066
[TBL] [Abstract][Full Text] [Related]
5. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.
Ando I; Morgan G; Levinsky RJ; Crawford DH
Clin Exp Immunol; 1986 Feb; 63(2):271-9. PubMed ID: 3009060
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
[TBL] [Abstract][Full Text] [Related]
7. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
Felton SC; Hoffmann CC; Kreier JP; Glaser R
Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
[TBL] [Abstract][Full Text] [Related]
8. In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients.
Yao QY; Rickinson AB; Gaston JS; Epstein MA
Int J Cancer; 1985 Jan; 35(1):43-9. PubMed ID: 2981781
[TBL] [Abstract][Full Text] [Related]
9. Human Ia-like-antigen-expressed cutaneous T cell lymphoma associated with Epstein-Barr virus infection.
Furukawa F; Oguchi M; Hashimoto M; Ohkawa S; Ozaki M; Imamura S
Dermatologica; 1982 Aug; 165(2):100-7. PubMed ID: 6292010
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr-virus-related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemia.
Forman SJ; Sullivan JL; Wright C; Ratech H; Racklin B; Blume KG
Transplantation; 1987 Aug; 44(2):244-9. PubMed ID: 2820089
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
13. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals.
Yao QY; Rickinson AB; Epstein MA
Int J Cancer; 1985 Jan; 35(1):35-42. PubMed ID: 2981780
[TBL] [Abstract][Full Text] [Related]
14. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Haque T; Thomas JA; Parratt R; Hunt BJ; Yacoub MH; Crawford DH
Transplantation; 1997 Oct; 64(7):1028-34. PubMed ID: 9381525
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
Gaston JS; Rickinson AB; Epstein MA
J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.
Gratama JW; Oosterveer MA; Zwaan FE; Lepoutre J; Klein G; Ernberg I
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8693-6. PubMed ID: 2847171
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression.
Gaston JS; Rickinson AB; Epstein MA
Lancet; 1982 Apr; 1(8278):923-5. PubMed ID: 6122768
[TBL] [Abstract][Full Text] [Related]
20. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
